A comparativw clinical study to evaluate the therapeutic effect of pippalyadi churna and sitophaladi churna in the management of kaphaja kasa VIS-A-VIS Allergic bronchitis
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- To reduce the respiratory complaints
研究概览
简要总结
Kasa is one of the most common diseases affecting the pranavaha srotas. If not treated, it may lead to dreadful diseases like Shwasa and Kshaya. According to the Acharyas, kasa is of 5 types, Kaphaja kasa being one among them. Kasa (cough) is the disease or symptom of respiratory tract occurring due to obstruction of Vata Dosha and its reverse movement and also a symptom of many other diseases. Kaphaja Kasa is dominated by Vata and Kapha and its nidana, samprapti, lakshanas, upadravas, and chikitsa are explainedin the classicS
The lakshanas of kaphaja kasa are similar to Allergic bronchitis or Chronic bronchitis & it has become more prevalent these days because of cigarette smoking. environmental pollution, occupational hazrds. In kaphaja kasa lakshanas are bahula, madhura, snigdha, swetha, nishtiva, ghana kapha, aruchi, gaurava, shirashoola, swarabheda, peenasa, kantha kandu, utklesha etc. Early intervention is necessary in case of kasa as it is a potential nidanarthkara vyadhi (disease itself become causative factor for other disease) to produce kshaya i.e depletion of bodily tissues/ dhatus. According to Ayurveda Chikitsa Siddhant, the prime treatment for Kaphaja Kasa is Nidana Parivarjana and the formulations which are Vata-kapha hara, Vatanulomana Agnideepana, Aama pachana and Srotoshodhaka. Keeping these points in mind an attempt is made to achieve these goals through Ayurvedic medicine. Pippalyadi churna is taken for the clinical study by considering the qualities of ingredients and cost effectiveness.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients with classical symptoms of kaphaja kasa bahula, madhura, shwet snigdha, nishtiva, ghana kapha, gourava, aruchi, shirashoola, swarabheda, peenasa, utklesha, mandagni Patients aged between 20-60 years of either gender.
- •Allergic bronchitis ranges from mild to moderate.
排除标准
- •Diagnosed patients with DM/HTN Diagnosed patients with Emphysema,CHD, Pnuemothorax, Septicemia, Haemoptysis, pneumonia, TB, Interstitial lung diseases Pregnant women and lactating mother Diagnosed patients with covid-19.
结局指标
主要结局
To reduce the respiratory complaints
时间窗: 15 days
次要结局
未报告次要终点
